Issues related to reimbursement for hemophilia services and treatments in Medicare Issues related to reimbursement for hemophilia services and treatments in Medicaid PBM Reform amendments to Medicaid and Medicare in Continuing Resolution draft legislation
2025 · 1st Quarter (Jan 1 - Mar 31)
THE HEMOPHILIA ALLIANCE
Filed by ARTEMIS POLICY GROUP LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- ARTEMIS POLICY GROUP LLC
- Client
- THE HEMOPHILIA ALLIANCE
- Filing UUID
- 7b68857a-c0f8-4d62-945b-18323a7bf5ad
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Affordable Care Act implementation Coverage of hemophilia treatments and services in private insurance plans Policies related to co-pay accumulators, including The HELP Copays Act (HR 864) Private insurance policies that discriminate coverage for high-cost drugs and use of patient assistance programs, also known as the (Alternative Payment Model) Patient Protection and Affordable Care Act; extension of the enhanced advance premium tax credits
Literal federal measure citations: HR 864
Issues related to participation in the 340B Drug Discount Program HR 3290, 340B Transparency bill SUSTAIN 340B ACT - Draft Senate 340B reform legislation HR 8574 - 340B ACCESS Act Polices related to PBMs and drug cost transparency
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.